Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

RUBICON

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 24
  • 0 comments

FDA approve POTASSIUM CHLORIDE

Comment Full text

WATSON LABS INC

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 34
  • 0 comments

FDA approve TADALAFIL

Comment Full text

ACTAVIS LABS FL INC

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 44
  • 0 comments

FDA approve NAPROXEN SODIUM

Comment Full text

JUBILANT CADISTA

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 38
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE

Comment Full text

ALEMBIC

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 37
  • 0 comments

FDA approve BETAMETHASONE VALERATE

Comment Full text

TEVA PHARMS

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 36
  • 0 comments

FDA approve QUININE SULFATE

Comment Full text

SANDOZ

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 43
  • 0 comments

FDA approve AMPICILLIN SODIUM; SULBACTAM SODIUM

Comment Full text

RISING

  • FDA Approval
  • Aug. 26, 2024, 08:41 UTC
  • 40
  • 0 comments

FDA approve PENTOSTATIN

Comment Full text

ZENARA PHARMA PRIVATE LTD

  • FDA Approval
  • Aug. 23, 2024, 15:33 UTC
  • 62
  • 0 comments

FDA approve TAFAMIDIS

Comment Full text

IMPAX LABS INC

  • FDA Approval
  • Aug. 23, 2024, 08:46 UTC
  • 53
  • 0 comments

FDA approve DEXMETHYLPHENIDATE HYDROCHLORIDE

Comment Full text
  • Previous
  • 368
  • 369
  • 370
  • 371
  • 372
  • Next

Search

News categories

  • Technical Exchange News(11514)
  • Event(3427)
  • SEC News(216616)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137764)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin